Russian vaccine for colon cancer ready to use: Report

Russia's Federal Medical Biological Agency (FMBA) has announced the successful completion of preclinical trials for its cancer vaccine, demonstrating safety and high efficacy. The vaccine, initially targeting colorectal cancer, showed significant reductions in tumor size and improved survival rates. Further advancements are being made in developing vaccines for glioblastoma and melanoma.